SCHEMBL18270680

SCHEMBL18270680

CCC(C)CCCS(I)(I)I

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25582562 0.77 LMNA (0.32) LMNA
SCHEMBL1805229 0.74 LMNA (0.50) LMNA
SCHEMBL2686925 0.74 LMNA (0.50) LMNA
SCHEMBL8813650 0.73 TP53 (0.30)
SCHEMBL21469680 0.73
SCHEMBL6856029 0.73
SCHEMBL17858277 0.73
SCHEMBL2134767 0.72 LMNA (0.47) LMNA
SCHEMBL4452016 0.72 LMNA (0.47) LMNA
SCHEMBL11216030 0.72 LMNA (0.47) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160346362-A1 METHODS AND COMPOSITIONS FOR TREATING CYTOMEGALOVIRUS INFECTIONS AGENOVIR CORPORATION 2016-12-01 US disclosed